This inventor holds 1 USPTO granted patent. Top assignee: Biovitrum Ab. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Wyeth Wasserman: Innovator in Diabetes Research
Introduction
Wyeth Wasserman is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of diabetes research through his innovative work. His expertise and dedication have led to advancements that may impact the treatment of diabetes.
Latest Patents
Wasserman holds a patent for a novel Afx response element, which comprises the nucleotide sequence AACATGTT. This sequence has a DNA binding site for the human fork head transcription factor Afx. The invention is particularly relevant for screening genes as potential drug targets for diabetes. It also plays a role in the bioinformatic analysis of the human genome, with implications for compounds that modify the insulin receptor signaling pathway.
Career Highlights
Wasserman is associated with Biovitrum AB, a company focused on biopharmaceuticals. His work there has been instrumental in advancing research related to diabetes and insulin signaling. His patent reflects his commitment to finding innovative solutions in the medical field.
Collaborations
Wasserman has collaborated with notable colleagues, including Isabel Climent-Johansson and Karin Dahlman-Wright. These partnerships have fostered a collaborative environment that enhances research outcomes.
Conclusion
Wyeth Wasserman's contributions to diabetes research through his patent and work at Biovitrum AB highlight his role as an innovator in the field. His efforts may pave the way for new treatments and understanding of diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile